Pulmonary Circulation
@PulmCirc
Followers
1K
Following
83
Media
180
Statuses
892
Medical research journal devoted to the field of pulmonary vascular disease, #pulmonaryhypertension and lung injury. RT or follow ≠ endorsement.
Tucson, USA & Cambridge, UK
Joined February 2013
Online First: A Checkpoint on Innate Myeloid Cells in Pulmonary Arterial Hypertension, by Andrew J. Bryant, et al. https://t.co/QZSIHHFeiM
0
0
6
More than 100M people in the U.S. live in communities where air pollution exceeds health-based air quality standards. Evidence suggests that, without more air pollution control efforts, climate change will increase the risk of unhealthy air quality. #NCA4 #ClimateCrisisCountdown
4
8
11
Online First: Assessment of Quality of Life in Pediatric Patients with Pulmonary Hypertension, by Stephanie S. Handler, et al. https://t.co/CHDjxZDbam
0
0
3
Online First: Paclitaxel Blocks Th2-Mediated TGF-β Activation in Schistosoma mansoni-Induced Pulmonary Hypertension, by Biruk Kassa, et al. https://t.co/QwyQzQidm0
0
2
6
Online First: Paclitaxel Blocks Th2-Mediated TGF-β Activation in Schistosoma mansoni-Induced Pulmonary Hypertension, by Biruk Kassa, et al. https://t.co/QwyQzQidm0
0
1
5
Royal Society publishing photography competition 2018 winners
theguardian.com
The Royal Society’s annual photography competition celebrates ‘the power of photography to capture science in its many forms’
1
32
71
Online First: Retinal vascular changes and right ventricular structure and function: The MESA-Right Ventricle and MESA-Eye Studies, by Anthony C. Chyou, et al. https://t.co/QWQQdHF01L
0
0
3
Online First: Clinical and Hemodynamic Factors in Predicting Response to Fluid Challenge during Right Heart Catheterization, by Nima Moghaddam, et al. https://t.co/QefDmRxG4p
0
0
3
Congratulations to one of our Editors-in-Chief, Nick Morrell!
. @Morphogen_IX, founded by our Fellow Professor Nick Morrell, has announced MGX292 as Clinical Development Candidate. This is an important step towards a disease modifying treatment for patients with PAH, with strong genetic validation of the target: https://t.co/iYELIi6EEA
0
0
7
Online First: Clinical and Hemodynamic Factors in Predicting Response to Fluid Challenge during Right Heart Catheterization, by Nima Moghaddam, et al. https://t.co/QefDmRPhsZ
0
2
6
Direct link to this study in Pulmonary Circulation: https://t.co/cRnhjvHBi3
Researchers at Vanderbilt Publish First Study from PHA’s 2018 Research Room
0
0
1
Proximal pulmonary arterial wall disease in patients with persistent pulmonary hypertension after successful left-sided valve replacement according to the hemodynamic phenotype, by Enric Domingo, et al. https://t.co/C3GqdSQGZ0
0
0
4
Online First! Imatinib for right heart failure in COPD, by Philipp Douschan, et al. https://t.co/o6MTUOTKWi
0
0
3
Online First: Adverse Physiologic Effects of Western Diet on Right Ventricular Structure and Function: Role of Lipid Accumulation and Metabolic Therapy, by Evan Brittain, et al. https://t.co/LS328sQjS4
0
3
5
Online First: SphK1/S1P mediates TGF-β1-induced proliferation of pulmonary artery smooth muscle cells and its potential mechanisms, by Jian Wang et al. https://t.co/UfuISGnlxM
0
0
1
Delighted to get to this key milestone for Morphogen-IX. Important step towards a disease modifying treatment for patients with PAH, with strong genetic validation of the target. Morphogen-IX Announces MGX292 as Clinical Development Candidate
newswire.com
Newswire offers a variety of flexible, cost-effective press release distribution services. Learn more about our global, national, and local PR distribution solutions.
1
17
44
Express Online: Value of lung perfusion scintigraphy in patients with idiopathic pulmonary arterial hypertension: a patchy pattern to consider, by Meng Wang, et al. https://t.co/K3ETzmokuI
0
1
2
Express Online: Proximal pulmonaryarterial wall disease in patients with persistent pulmonary hypertension aftersuccessful left-sided valve replacement according to the hemodynamic phenotype, by Enric Domingo, et al. https://t.co/C3GqdSQGZ0
0
1
3
Express Online: Imatinib for right heart failure in COPD, by Philipp Douschan, et al. https://t.co/o6MTUOCa4K
0
0
3
Moving account from a parent of a child with PAH. We need better treatments for this devastating condition.
“Your son has a very rare disease: pulmonary hypertension, invariably fatal.” @Elaine_Pagels remembers nothing else that the doctor said, until finally she asked, “How long?” “We don’t know; a few months, maybe a few years.” https://t.co/WNNtdBuTB3
2
19
33